Vivani Medical, Inc. (VANI)
2025-06-30 | ||||
|---|---|---|---|---|
| Other income, net | 318 | |||
| Research and development, net of grants | 4,759 | |||
| General and administrative, net of grants | 2,703 | |||
| Total operating expenses | 7,462 | |||
| Loss from operations | -7,462 | |||
| Net loss | -7,144 | |||
| Net loss per common share - basic (in dollars per share) | -0.12 | |||
| Net loss per common share - diluted (in dollars per share) | -0.12 | |||
| Weighted average common shares outstanding - basic (in shares) | 59,244,000 | |||
| Weighted average common shares outstanding - diluted (in shares) | 59,244,000 | |||